Coherent Market Insights: Market Research and B2B Consulting

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Cancer Type
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Increasing incidence of skin cancers
  - High costs of targeted therapies
  - Combination therapies
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Mergers, Acquisitions, and Collaborations
Global Skin Cancer Drugs Market, By Drug Type, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Chemotherapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Targeted Therapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Immunotherapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hormone Therapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others (Photodynamic Therapy, Cryotherapy and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Skin Cancer Drugs Market, By Cancer Type, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Basal cell carcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Squamous cell carcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Melanoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others (Kaposi's sarcoma, Mycosis fungoides and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Skin Cancer Drugs Market, By Route of Administration, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others (Surgical procedures, radiation therapy and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Skin Cancer Drugs Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Global Skin Cancer Drugs Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, By Sub-region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Sub-region, 2022 –2033
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(US$ Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Company Profile
  - Novartis
    - Company Highlights
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Strategies
  - Merck
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Roche
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Amgen
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Pfizer
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sun Pharma
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bristol-Myers Squibb
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AstraZeneca
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Johnson & Johnson
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Valeant
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Daiichi Sankyo
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Takeda Pharmaceutical
    - Company Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - LEO Pharma
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Mylan N.V.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Regeneron
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Eli Lilly
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bayer
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Gilead Sciences
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Astellas Pharma
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us

*Browse 25 market data tables and 29 figures on “Global Skin Cancer Drugs Market” - Global forecast to 2033

SKIN CANCER DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Research Objectives and Assumptions

Market Purview

Market Dynamics, Regulations, and Trends Analysis

Global Skin Cancer Drugs Market, By Drug Type, 2021 - 2033, (US$ Bn)

Global Skin Cancer Drugs Market, By Cancer Type, 2021 - 2033, (US$ Bn)

Global Skin Cancer Drugs Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Global Skin Cancer Drugs Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Global Skin Cancer Drugs Market, By Region, 2021 - 2033, (US$ Bn)

Competitive Landscape

Section